“Clinical Predictors of Response to Treatment With Tofacitinib (Janus Kinase Inhibitor) in Patients With Ankylosing Spondylitis”. Indus Journal of Bioscience Research, vol. 3, no. 4, Apr. 2025, pp. 175-81, https://doi.org/10.70749/ijbr.v3i4.1020.